Explore

Capbase

Cadrenal Therapeutics, Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$8.8MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Cadrenal Therapeutics, Inc. filed a Form D notice of exempt offering with the SEC.

1 rounds

No investors recorded yet for Cadrenal Therapeutics, Inc..

Leadership

Quang X. PhamExecutive Officer · Chairman of the Board and Chief Executive OfficerSince 2026Source: [SEC]

John P. SharpExecutive Officer · Interim Chief Financial OfficerSince 2026Source: [SEC]

Showing 2 of 7 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Cadrenal Therapeutics, Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Cadrenal Therapeutics, Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.